A potential mechanism for the connection between breast cancer development and inflammatory bowel disease is that the abnormal immune environment in the breast and the systemic inflammatory reaction leads to downregulation of breast cancer resistance protein (BCRP) and upregulation of G-protein-coupled estrogen receptors (GPER) on the breast cells’ membranes. The gene discussed is ABCG2; the disease is breast cancer.